These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 30785480)
1. Pre-analytical parameters associated with unsuccessful karyotyping in myeloid neoplasm: a study of 421 samples. Santos MFM; Oliveira FCAC; Kishimoto RK; Borri D; Santos FPS; Campregher PV; Silveira PAA; Hamerschlak N; Mangueira CLP; Duarte FB; Crepaldi AH; Salvino MA; Velloso EDRP Braz J Med Biol Res; 2019 Feb; 52(2):e8194. PubMed ID: 30785480 [TBL] [Abstract][Full Text] [Related]
2. Histopathology in the diagnosis and classification of acute myeloid leukemia, myelodysplastic syndromes, and myelodysplastic/myeloproliferative diseases. Orazi A Pathobiology; 2007; 74(2):97-114. PubMed ID: 17587881 [TBL] [Abstract][Full Text] [Related]
3. Polysomy 8 defines a clinico-cytogenetic entity representing a subset of myeloid hematologic malignancies associated with a poor prognosis: report on a cohort of 12 patients and review of 105 published cases. Beyer V; Mühlematter D; Parlier V; Cabrol C; Bougeon-Mamin S; Solenthaler M; Tobler A; Pugin P; Gregor M; Hitz F; Hess U; Chapuis B; Laurencet F; Schanz U; Schmidt PM; van Melle G; Jotterand M Cancer Genet Cytogenet; 2005 Jul; 160(2):97-119. PubMed ID: 15993266 [TBL] [Abstract][Full Text] [Related]
4. Diagnosing myelodysplastic/myeloproliferative neoplasms: laboratory testing strategies to exclude other disorders. Hall J; Foucar K Int J Lab Hematol; 2010 Dec; 32(6 Pt 2):559-71. PubMed ID: 20670271 [TBL] [Abstract][Full Text] [Related]
5. 7q22 deletion in myeloid malignancies: be attentive to the design of the FISH probe. Struski S; Luquet I Ann Biol Clin (Paris); 2019 Apr; 77(2):229-230. PubMed ID: 30907375 [No Abstract] [Full Text] [Related]
14. Fluorescence in situ hybridization reveals closely correlated results in cytological and histological specimens of hematological neoplasias compared to conventional cytogenetics. Gerr H; Gadzicki D; Kreipe H; Schlegelberger B; Wilkens L Pathobiology; 2006; 73(6):271-9. PubMed ID: 17374964 [TBL] [Abstract][Full Text] [Related]
15. Challenges in the introduction of next-generation sequencing (NGS) for diagnostics of myeloid malignancies into clinical routine use. Bacher U; Shumilov E; Flach J; Porret N; Joncourt R; Wiedemann G; Fiedler M; Novak U; Amstutz U; Pabst T Blood Cancer J; 2018 Nov; 8(11):113. PubMed ID: 30420667 [TBL] [Abstract][Full Text] [Related]
16. Bone Marrow Conventional Karyotyping and Fluorescence In Situ Hybridization: Defining an Effective Utilization Strategy for Evaluation of Myelodysplastic Syndromes. He R; Wiktor AE; Durnick DK; Kurtin PJ; Van Dyke DL; Tefferi A; Patnaik MS; Ketterling RP; Hanson CA Am J Clin Pathol; 2016 Jul; 146(1):86-94. PubMed ID: 27353768 [TBL] [Abstract][Full Text] [Related]
17. The value of cell cultures for the diagnosis of mixed myelodysplastic/myeloproliferative disorders. Del Cañizo MC; Brufau A; Mota A; Lopez N; Fernandez ME; Vallejo C; Hernandez JM; Garcia JL; San Miguel JF Haematologica; 1998 Jan; 83(1):3-7. PubMed ID: 9580461 [TBL] [Abstract][Full Text] [Related]
18. Editorial: The role of cytogenetics in hematology. Rowley JD Blood; 1976 Jul; 48(1):1-7. PubMed ID: 1065388 [No Abstract] [Full Text] [Related]
19. Improving the differential diagnosis between myelodysplastic syndromes and reactive peripheral cytopenias by multiparametric flow cytometry: the role of B-cell precursors. Reis-Alves SC; Traina F; Metze K; Lorand-Metze I Diagn Pathol; 2015 Apr; 10():44. PubMed ID: 25924846 [TBL] [Abstract][Full Text] [Related]
20. Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms (Excluding Acute Leukemias). Hasserjian RP; Kelley TW; Weinberg OK; Morgan EA; Fend F Am J Clin Pathol; 2019 Aug; 152(3):302-321. PubMed ID: 31263893 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]